{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:57:40Z","timestamp":1791424660861,"version":"4.3.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation","doi-asserted-by":"publisher","award":["2011011038-1"],"award-info":[{"award-number":["2011011038-1"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.yexmp.2015.07.012","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T23:02:22Z","timestamp":1438210942000},"page":"297-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma"],"prefix":"10.1016","volume":"99","author":[{"given":"Yanfeng","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2015.07.012_bb0005","doi-asserted-by":"crossref","first-page":"19678","DOI":"10.1073\/pnas.0811166106","article-title":"MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17\u201392, E2F, and Myc","volume":"105","author":"Aguda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-230X(10)07006-5","article-title":"MYC in oncogenesis and as a target for cancer therapies","volume":"107","author":"Albihn","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0015","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-11-0224","article-title":"MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"17","author":"Alencar","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0020","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","article-title":"Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence","volume":"121","author":"Bonn","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0025","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1182\/blood-2011-02-336842","article-title":"Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia","volume":"117","author":"Bonnet","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0030","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2141.2006.06237.x","article-title":"Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation","volume":"134","author":"Chang","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10428190902926999","article-title":"Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea","volume":"50","author":"Chang","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","article-title":"Expression profiles of MYC protein and MYC gene rearrangement in lymphomas","volume":"39","author":"Chisholm","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","article-title":"Lymphoblastic lymphoma","volume":"79","author":"Cortelazzo","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrclinonc.2010.167","article-title":"Prognostic factors in chronic lymphocytic leukemia\u2014what do we need to know?","volume":"8","author":"Cramer","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0060","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1182\/blood-2012-05-402784","article-title":"The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas","volume":"120","author":"Di Lisio","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MOH.0b013e3283476012","article-title":"Role of microRNAs in lymphoid biology and disease","volume":"18","author":"Fabbri","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11899-012-0123-4","article-title":"Recent developments in the management of T-cell precursor acute lymphoblastic leukemia\/lymphoma","volume":"7","author":"Fielding","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0085","first-page":"800","article-title":"MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival","volume":"8","author":"Ge","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0090","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0095","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3109\/10428194.2013.766731","article-title":"MicroRNAs in mantle cell lymphoma","volume":"54","author":"Husby","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0100","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1182\/blood-2011-07-370122","article-title":"Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis","volume":"119","author":"Iqbal","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbagrm.2014.04.003","article-title":"MicroRNAs as regulators and mediators of c-MYC function","volume":"2015","author":"Jackstadt","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4161\/cc.27784","article-title":"microRNA-17~92 is a powerful cancer driver and a therapeutic target","volume":"13","author":"Jin","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0115","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12185-014-1585-z","article-title":"Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols","volume":"99","author":"Kobayashi","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/bjh.12157","article-title":"MicroRNAs and lymphomagenesis: a functional review","volume":"160","author":"Lawrie","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0125","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Mogilyansky","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0130","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","article-title":"Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas","volume":"23","author":"Mu","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0135","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B cell lymphomas: how a complex biology gets more complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0140","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/1078-0432.CCR-12-3077","article-title":"microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics","volume":"19","author":"Navarro","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"O'Donnell","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0150","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jcp.2008.058339","article-title":"Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR","volume":"62","author":"Siebolts","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00441-012-1438-0","article-title":"Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action","volume":"349","author":"Ul Hussain","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0165","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0170","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.humpath.2012.08.023","article-title":"Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T lymphoblastic lymphoma\/leukemia","volume":"44","author":"Xi","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2015.07.012_bb0175","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/leu.2011.33","article-title":"Microarray detection of multiple recurring submicroscopic chromosomal aberrations in pediatric T-cell acute lymphoblastic leukemia","volume":"25","author":"Yu","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2015.07.012_bb0180","doi-asserted-by":"crossref","first-page":"e56718","DOI":"10.1371\/journal.pone.0056718","article-title":"Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia","volume":"8","author":"Zhi","year":"2013","journal-title":"PLoS One"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015001604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015001604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T15:51:15Z","timestamp":1537458675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480015001604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0014480015001604"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.07.012","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}